Literature DB >> 33652790

The Prevalence of Ureaplasma Urealyticum and Mycoplasma Hominis Infections in Infertile Patients in the Northeast Region of Romania.

Bogdan Doroftei1,2,3, Ovidiu-Dumitru Ilie4, Theodora Armeanu1,2,3, Emil Anton1,2,3, Ioana Scripcariu1, Radu Maftei1,2,3.   

Abstract

Background and objectives: Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) are two commensal microorganisms that form the urogenital microbiota. Under a state of dysbiosis, both bacteria cause intrauterine infection. Material and methods: Therefore, the purpose of the present study was to analyze the prevalence of UU and MH among four hundred and eleven infertile women.
Results: Women between thirty and thirty-five years old were the most affected group, followed by those that were 25 and 30 years old, respectively. Cumulatively, the prevalence of single UU and MH, and coinfection, was 28.46% (n = 117), (n = 2) 0.48%, and 2.91% (n = 12), respectively, with an overall detection rate of 31.87% (n = 131). To assess the associated drug susceptibility, endocervical samples were unequally sent to Regina Maria (n = 281) and Synevo (n = 130) laboratories for further analyses. Pristinamycin (100% vs. 100%) and Josamycin (100% vs. 98.00%) were the most efficient antibiotics in eradicating UU and MH, several others also displaying a high efficiency, among which can be mentioned Doxycycline (98.23%), Minocycline (96.00%), Tetracycline (96.48% vs. 68.00%), and Erythromycin (70.17% vs. 92.00%). Based on antibiograms, Clarithromycin (88.00%), Roxithromycin (88.00%), Levofloxacin (82.00%), and Azithromycin (78.94%) can be further used in treating such infections. On the other hand, Clindamycin (4.00%) and Ciprofloxacin (12.27% vs. 2.00%) are no longer viable because both UU and MH display an intermediate response towards gained resistance. Interestingly, the efficiency of Ofloxacin (22.79% vs. 60.00%) was conflicting, this possibly suggesting a transient stage to a gradual adaptability of these microorganisms to Ofloxacin. Conclusions: The most susceptible age groups in each case were women that were between twenty and forty years old. It can be concluded that four antibiotics can be safely used for treating UU, MH, or dual infections whose efficiency was over 95%.

Entities:  

Keywords:  Mycoplasma hominis; Ureaplasma urealyticum; drug susceptibility; infertility; prevalence

Year:  2021        PMID: 33652790      PMCID: PMC7996858          DOI: 10.3390/medicina57030211

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  31 in total

Review 1.  Seminal tract infections: impact on male fertility and treatment options.

Authors:  C Keck; C Gerber-Schäfer; A Clad; C Wilhelm; M Breckwoldt
Journal:  Hum Reprod Update       Date:  1998 Nov-Dec       Impact factor: 15.610

2.  Viral and bacterial aetiologies of epithelial ovarian cancer.

Authors:  S Shanmughapriya; G Senthilkumar; K Vinodhini; B C Das; N Vasanthi; K Natarajaseenivasan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-09       Impact factor: 3.267

3.  Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium.

Authors:  David Taylor-Robinson
Journal:  Res Microbiol       Date:  2017-03-02       Impact factor: 3.992

4.  Association of cervical infection of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis with peritoneum colonisation in pregnancy.

Authors:  Y Aydin; A Atis; F Ocer; R Isenkul
Journal:  J Obstet Gynaecol       Date:  2010       Impact factor: 1.246

5.  Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile men.

Authors:  Mario Salmeri; Daniela Valenti; Sandro La Vignera; Salvatore Bellanca; Angela Morello; M Antonietta Toscano; Silvana Mastrojeni; Aldo E Calogero
Journal:  J Chemother       Date:  2012-04       Impact factor: 1.714

Review 6.  Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome.

Authors:  Sourav Sanchit Patnaik; Antonio Simone Laganà; Salvatore Giovanni Vitale; Salvatore Butticè; Marco Noventa; Salvatore Gizzo; Gaetano Valenti; Agnese Maria Chiara Rapisarda; Valentina Lucia La Rosa; Carlo Magno; Onofrio Triolo; Vani Dandolu
Journal:  Arch Gynecol Obstet       Date:  2017-04-08       Impact factor: 2.344

7.  The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.

Authors:  Robert L Goldenberg; William W Andrews; Alice R Goepfert; Ona Faye-Petersen; Suzanne P Cliver; Waldemar A Carlo; John C Hauth
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

8.  Ureaplasma urealyticum and Mycoplasma hominis detected by the polymerase chain reaction in the cervices of women undergoing in vitro fertilization: prevalence and consequences.

Authors:  S S Witkin; I Kligman; J A Grifo; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

9.  Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China.

Authors:  Chuan Huang; Xingyu Long; Shuang Jing; Liqing Fan; Kongrong Xu; Siyang Wang; Wenbing Zhu
Journal:  World J Urol       Date:  2015-11-04       Impact factor: 4.226

10.  Examination of Ureaplasma urealyticum and Mycoplasma hominis in 4082 Chinese patients.

Authors:  Wei-Wei Zheng; Wen-Jing Zhang; Di Cui; Zheng-Chao Nie; Bang-Sheng Ding; Jiang-Hua Cheng; Chuan-Zhong Mei
Journal:  Braz J Med Biol Res       Date:  2020-11-27       Impact factor: 2.590

View more
  3 in total

1.  Detection and Evaluation of Macrolide Resistance (Erythromycin) in Mycoplasma hominis Isolated from Endocervical Specimens of Patients Referring to Ibn Sina Infertility Treatment Centre, Tehran, Iran.

Authors:  Faezeh Nazarzadeh; Mohammad Hossein Ahmadi; Soheila Ansaripour; Mohammad Niakan; Iman Pouladi
Journal:  Int J Fertil Steril       Date:  2022-05-08

2.  Risk Prediction of Ureaplasma urealyticum Affecting Sperm Quality Based on Mathematical Model and Cross-Sectional Study.

Authors:  Huang Liu; Kai Yang; Liping He; Shenghui Zhu; Tao Pang; Zhiyong Zhu; Yunyi Yao; Houbin Zheng; Qingqi Zeng; Xinzong Zhang
Journal:  Comput Math Methods Med       Date:  2022-05-25       Impact factor: 2.809

3.  Prevalence and antibiotics resistance of Ureaplasma species and Mycoplasma hominis in Hangzhou, China, from 2013 to 2019.

Authors:  Jingjuan Song; Xuanlan Wu; Yingying Kong; Hong Jin; Ting Yang; Xinyou Xie; Jun Zhang
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.